N‐acetylation polymorphism of dapsone in a Japanese population.
Open Access
- 1 April 1988
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 25 (4) , 487-494
- https://doi.org/10.1111/j.1365-2125.1988.tb03333.x
Abstract
1. The N-acetylation of dapsone (DDS) was studied in 182 unrelated healthy Japanese subjects. The frequency of slow acetylators determined using the plasma monoacetyldapsone (MADDS) to DDS ratio (MADDS/DDS, slow acetylators less than 0.30 and rapid acetylators greater than 0.35) at 3 h after an oral dose of DDS (100 mg) was 6.6% (12 of the 182 subjects) with a 95% confidence interval of 3.8 to 11.2%. 2. The frequency distribution histogram of the plasma MADDS/DDS ratio showed an apparent trimodal pattern. However, the numbers of heterozygous (n = 105) and homozygous rapid acetylators (n = 65) derived from the observed data did not agree with those predicted for the respective rapid acetylators (n = 70, and n = 100) by applying the Hardy-Weinberg Law, when the suggested antimode of 0.85 discriminating these two rapid acetylators was employed. 3. The incidence of slow acetylators was unexpectedly lower in the males (1.4%, 1 of the 69 subjects, with a 95% confidence interval of 0.2 to 7.7%) compared with the incidence in the females (9.7%, 11 of the 113 subjects, with a 95% confidence interval of 5.5 to 16.6%). The difference reached a marginally significant level (Fisher's exact probability test, P = 0.02). 4. The mean plasma concentration of MADDS was significantly (P less than 0.001) lower in the slow compared to the rapid acetylators and there was a highly significant correlation (rs = 0.757, P less than 0.001) between plasma MADDS levels and MADDS/DDS ratios. 5. Slow acetylators showed a significantly (P less than 0.001) lower urinary MADDS/DDS ratio and excreted less (P less than 0.001) MADDS than rapid acetylators.(ABSTRACT TRUNCATED AT 250 WORDS)This publication has 29 references indexed in Scilit:
- Isoniazid disposition, comparison of isoniazid phenotyping methods in and acetylator distribution of Japanese patients with idiopathic systemic lupus erythematosus and control subjects.Published by Wiley ,1982
- Acetylator phenotyping: A comparison of the isoniazid and dapsone testsEuropean Journal of Clinical Pharmacology, 1981
- Dapsone in Saliva and Plasma of ManPharmacology, 1981
- Kinetic discrimination of three sulfamethazine acetylation phenotypesClinical Pharmacology & Therapeutics, 1980
- Plasma and salivary pharmacokinetics of dapsone estimated by a thin layer chromatographic methodEuropean Journal of Clinical Pharmacology, 1980
- Simultaneous analysis of dapsone and monoacetyldapsone employing high performance liquid chromatography: a rapid method for determination of acetylator phenotype.British Journal of Clinical Pharmacology, 1978
- Clinical consequences of polymorphic acetylation of basic drugsClinical Pharmacology & Therapeutics, 1977
- Disease and Acetylation PolymorphismClinical Pharmacokinetics, 1977
- The polymorphic acetylation of dapsone in manClinical Pharmacology & Therapeutics, 1971
- Genetic Control of Isoniazid Metabolism in ManBMJ, 1960